Your biopharma team, from molecule design to portfolio strategy
Quinn is your biopharma team. From molecule design to portfolio strategy, Quinn delivers comprehensive reports and supporting analyses, models and designs in 3–5 days instead of months.
Active Founders
Founder/CEO
Daniel Gomari is the founder and CEO of Quinn. A Stanford postdoc and PhD in Computational Biology, his work spanned ML for drug repurposing across cancer and metabolic disease, and multi-omics studies on aging and lifespan extension. He built Quinn after watching the pharma industry make billion-dollar R&D decisions on intuition and slide decks instead of computational evidence.
Daniel Gomari is the founder and CEO of Quinn. A Stanford postdoc and PhD in Computational Biology, his work spanned ML for drug repurposing across cancer and metabolic disease, and multi-omics studies on aging and lifespan extension. He built Quinn after watching the pharma industry make billion-dollar R&D decisions on intuition and slide decks instead of computational evidence.
